Short-term exposure of human sebocytes to 13-cis-retinoic acid induces acnegenic changes

Autor: Burney, W, Bosanac, SS, Nguyen, C, Isseroff, RR, Sivamani, RK

Publikováno v: Burney, W; Bosanac, SS; Nguyen, C; Isseroff, RR; & Sivamani, RK. (2018). Short-term exposure of human sebocytes to 13-cis-retinoic acid induces acnegenic changes. British Journal of Dermatology. doi: 10.1111/bjd.16837. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/4476s6mf

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::980466a471859e4a212794bfaefa8045
http://www.escholarship.org/uc/item/4476s6mf

Human sebum requires de novo lipogenesis, which is increased in acne vulgaris and suppressed by acetyl-CoA carboxylase inhibition.

Autor: Esler WP; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA. william.esler@pfizer.com., Tesz GJ; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Hellerstein MK; KineMed Inc., Emeryville, CA 94608, USA.; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA., Beysen C; KineMed Inc., Emeryville, CA 94608, USA., Sivamani R; Department of Dermatology, School of Medicine, University of California, Davis, Davis, CA 95816, USA., Turner SM; KineMed Inc., Emeryville, CA 94608, USA., Watkins SM; Verso Biosciences, Davis, CA 95618, USA., Amor PA; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Carvajal-Gonzalez S; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Geoly FJ; Drug Safety Research and Development, Pfizer Global Research and Development, Groton, CT 06340, USA., Biddle KE; Drug Safety Research and Development, Pfizer Global Research and Development, Groton, CT 06340, USA., Purkal JJ; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Fitch M; Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA., Buckeridge C; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Silvia AM; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Griffith DA; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Gorgoglione M; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Hassoun L; Department of Dermatology, School of Medicine, University of California, Davis, Davis, CA 95816, USA., Bosanac SS; Department of Dermatology, School of Medicine, University of California, Davis, Davis, CA 95816, USA., Vera NB; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Rolph TP; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Pfefferkorn JA; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA., Sonnenberg GE; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Global Research and Development, Cambridge, MA 02139, USA.

Publikováno v: Science translational medicine [Sci Transl Med] 2019 May 15; Vol. 11 (492).

Emerging Therapies for Acne Vulgaris.

Autor: Trivedi MK; School of Medicine, University of Michigan, Ann Arbor, MI, USA., Bosanac SS; School of Medicine, University of California-Davis, Sacramento, CA, USA., Sivamani RK; Department of Dermatology, University of California, Davis, 3301 C Street, Suite 1400, Sacramento, CA, 95816, USA.; Department of Biological Sciences, California State University, Sacramento, CA, USA., Larsen LN; Department of Dermatology, University of California, Davis, 3301 C Street, Suite 1400, Sacramento, CA, 95816, USA. lnlarsen@ucdavis.edu.

Publikováno v: American journal of clinical dermatology [Am J Clin Dermatol] 2018 Aug; Vol. 19 (4), pp. 505-516.

Randomized and controlled pilot study of the pragmatic use of mobile phone based follow up of actinic keratoses treated with topical 5-fluorouracil.

Autor: Bosanac SS, Nguyen V, Bui D, Eisen DB, Sivamani RK; Department of Dermatology, University of California, Davis, Sacramento, California Department of Biological Sciences, California State University, Sacramento, California. raja.sivamani.md@gmail.com.

Publikováno v: Dermatology online journal [Dermatol Online J] 2018 Apr 15; Vol. 24 (4). Date of Electronic Publication: 2018 Apr 15.